These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6640893)

  • 1. Intrinsic and extrinsic asthma, a shared lymphocyte abnormality.
    Swinburn CR; Hudspith BN; Brostoff J; Johnson NM
    Clin Allergy; 1983 Nov; 13(6):571-6. PubMed ID: 6640893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma.
    Bentley AM; Durham SR; Kay AB
    J Investig Allergol Clin Immunol; 1994; 4(5):222-32. PubMed ID: 7874318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prostaglandins in the modulation of histamine suppression of mitogen responses in atopic and normal subjects.
    Hall TJ; Hudspith BN; Brostoff J
    Int J Immunopharmacol; 1983; 5(2):107-14. PubMed ID: 6874163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of extrinsic and intrinsic asthma.
    Walker C
    Agents Actions Suppl; 1993; 43():97-106. PubMed ID: 8368174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte transformation in extrinsic bronchial asthma.
    Thomson NC; Macdonald C; Kirkwood E
    Clin Allergy; 1978 Sep; 8(5):487-91. PubMed ID: 709795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study of concanavalin A-induced histamine release utilizing a single isotopic enzymatic assay of histamine.
    Morita Y; Matsumoto Y; Miyamoto T; Horiuchi Y
    Ann Allergy; 1978 Jan; 40(1):47-50. PubMed ID: 74962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of indomethacin on lymphocyte proliferation, suppressor cell function, and leukocyte migration inhibitory factor (lmif) production.
    Soppi E; Eskola J; Ruuskanen O
    Immunopharmacology; 1982 Jun; 4(3):235-42. PubMed ID: 6213582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin enhancement of immunocompetence in melanoma patients.
    Tilden AB; Balch CM
    Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases.
    Vignola AM; Chanez P; Chiappara G; Merendino A; Zinnanti E; Bousquet J; Bellia V; Bonsignore G
    Clin Exp Immunol; 1996 Oct; 106(1):114-9. PubMed ID: 8870708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of cancer patients' lymphocytes to mitogen. The effect of indomethacin on adherent and non-adherent cells activity.
    Pituch-Noworolska A
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):161-5. PubMed ID: 7305629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of prostaglandin E2 and indomethacin in modulating Con A-induced human lymphocyte proliferation and suppressor cell development.
    Skoldstam L; Zoschke D; Messner R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):32-42. PubMed ID: 6217939
    [No Abstract]   [Full Text] [Related]  

  • 12. Histamine suppression of lymphocyte activation.
    Brostoff J; Pack S; Lydyard PM
    Clin Exp Immunol; 1980 Mar; 39(3):739-45. PubMed ID: 6966551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of mitogen-induced proliferative responses by in vitro indomethacin in patients with acquired immune deficiency syndrome and AIDS-related complex.
    Reddy MM; Manvar D; Ahuja KK; Moriarty ML; Grieco MH
    Int J Immunopharmacol; 1985; 7(6):917-21. PubMed ID: 4077348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the effect of indomethacin and preincubation on the lymphoproliferative response to concanavalin A of spleen cells from low responder C57BL/6 and high responder BALB/c mice.
    Malavé I; Araujo Z
    Int J Immunopharmacol; 1986; 8(2):137-46. PubMed ID: 3710662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial precipitins and their immunoglobulin class in atopic asthma, non-atopic asthma, and chronic bronchitis.
    Davies RJ; Holford-Strevens VC; Wells ID; Pepys J
    Thorax; 1976 Aug; 31(4):419-24. PubMed ID: 9702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of phospholipid platelet activation factor on proliferation of B-lymphocytes of the peripheral blood of healthy donors and patients with bronchial asthma].
    Orlov SM; Vlasov AA; Savel'eva VF; Lipatkina LIu; Kulikov VI
    Biull Eksp Biol Med; 1991 Apr; 111(4):392-4. PubMed ID: 1893146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients.
    Han T; Takita H
    Cancer; 1980 Dec; 46(11):2416-20. PubMed ID: 6969110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810).
    Rocklin RE; Hemady Z; Matloff S; Kiselis I; Lima M
    Int J Immunopharmacol; 1984; 6(1):1-8. PubMed ID: 6233230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics.
    Folkard SG; Westwick J; Millar AB
    Eur Respir J; 1997 Sep; 10(9):2097-104. PubMed ID: 9311510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up.
    Ulrik CS; Backer V; Dirksen A
    J Asthma; 1992; 29(1):29-38. PubMed ID: 1544881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.